chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash at the injection site and a sore arm with the other 3 doses; Rash at the injection site and a sore arm with the other 3 doses; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site and a sore arm with the other 3 doses) and PAIN IN EXTREMITY (Rash at the injection site and a sore arm with the other 3 doses) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011a21a, 044a21a and 017e21a) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic, Thyroid disorder NOS, Cholesterol and Blood pressure.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash at the injection site and a sore arm with the other 3 doses) and PAIN IN EXTREMITY (Rash at the injection site and a sore arm with the other 3 doses). At the time of the report, VACCINATION SITE RASH (Rash at the injection site and a sore arm with the other 3 doses) and PAIN IN EXTREMITY (Rash at the injection site and a sore arm with the other 3 doses) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications included cholesterol medication, blood pressure medication and thyroid medication.  The patient never had COVID positive test or diagnosis. The patient had no other vaccines within 1 month prior to Moderna COVID-19 vaccine. There was no medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. The AE did not cause patient to seek medical care (office visit, Urgent care, ER, hospitalized). The patient did not experience a similar event in the past.  Treatment medication was not reported.   This case was linked to MOD-2022-613363 (Patient Link).
Patient called pharmacy about 5:30PM on 9/2/11 and said that her right hand is numb particularly around the thumb region.  She said it started about 20 minutes after receiving the flu shot (received at 3:30 PM in right deltoid). I followed up with the patient at 7:00PM on 9/2/11 and she said the numbness is still there but it is getting better.  I spoke with her again at 8:45PM that evening and she said the numbness was finally gone.  I followed up with her again on 9/3 at 10:15AM and she said the numbness has not returned and her hand is fine.  She did say she was currently having a really bad headache which began on 9/2 (late evening before bedtime) and was still present at 10:15AM on 9/3.  She took 2 Ibuprofen (200mg strength) but she was relieved her hand was back to normal.
Hot flashes; This is a spontaneous report from a contactable Nurse(patient)  A 41-years-old no pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 14Feb2021 19:45 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation  .  Medical history included none from an unknown date and unknown if ongoing.     There were no concomitant medications.  The patient experienced hot flashes) (non-serious) on 22Feb2021 with outcome of not recovered. No treatment received. Additional information: Facility type vaccine: Hospital;No other vaccine in four weeks.No  Covid prior vaccination.No Covid tested post vaccination  No follow up attempts are possible; information on Lot/batch number cannot be obtained.
intermittent pain on my left hand-arm only: from fingers to elbow The pain came like waves, intensified within 5-10 minutes, and stayed at that pain level:6 for 2 hours. At that time I couldn't use my left hand at all. The total duration of each episode is around 4-5 hours and it almost turned to normal afterward.   I had 6 cycles of intermittent pain.    02/08/2021:  one in the afternoon, one in the evening It started on my fingers (left hand). restriction with the movement due to pain and weakness. I could still hold objects but it hurt and I didn't want to use my left hand at all.  I took OTC ibuprofen in the afternoon, but it didn't help.   02/09/2021: woke up at 6-7 am due to pain. the pain reached to my elbow.  total of 3 pain cycles.   02/11/2021: 1 mild pain cycle and then the pain resolved.
The following day I had fatigue,  body ache, and a fever of 100.4. I felt better after one day. The following week, day 8, I started feeling a tingling, burning sensation on my lower body, front and back. The next 2 days I found rashes on the front of my belly and groin, and on my buttocks all on the right side of my body. Then on Friday  6/16/23 on had a low fever of again up to 100.4 with fatigue, chills, and body ache. Also, and this may be unrelated, but at the same time the rashes formed,  I had a flare up of my sciatic nerve also on my right side. I am still feeling all these symptoms
Patient complained of nausea and a "itchy" throat after receiving her 2nd Covid vaccination and declined an epinephrine injection. She was taken to the Emergency Department via ambulance.
On 5/17, the patient reports that after receiving each dose he could not sleep for several days. Patient also reports numbness in hands following second dose. All adverse events have resolved.
This medically confirmed spontaneous report (initial receipt: 18-Jun-2012) concerns a female patient, who was allergic to latex. The patient had 'an allergic reaction' to influenza vaccine (manufacturer unknown) 'years ago'. She sought medical attention. The patient was not able to confirm the manufacturer of the influenza vaccine or to provide any further details. The event outcome was recovered.
developed headache after going to bed night of getting vaccine.  took Tylenol and headache was gone when I woke up.
A nurse reported that an 18 month old female received an injection of Prevnar on 11/12/02 in the right deltoid. On 11/13/02, the child developed a fever to 102.4 deg F, fussiness, and an injection site reaction characterized by a "2 inch" area of redness and soreness. On 11/14/02, the mother indicated that the child's temperature was 99 deg F. *She recovered* This is one of two patients from the same facility who experienced this event following the receipt of Prevnar lot 485-989.
Complain of left arm discomfort " in bone" 3 weeks after vaccination, complain of decrease range of motion from Friday with resolution on Monday 07/24, swelling and redness to right jaw.  Complain of taste that morning and night.  Swelling resolved with ice.  Continue with complain of soreness.
Tingling and numbing of both of my arms,  hands, and fingers on both hands.
Severe pain, tenderness and redness of the puncture vaccination arm. Rx.: Cold pack, analgesics and antihistaminic tablets. Fioricet for severe headache.
Lightheadedness: onset few minutes post dose gave 25 mg BENADRYL and Gatorade which resolved it in a couple minutes. Followed up.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 13-NOV-2012 10:55, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. it was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Patient received vaccine on 9/11/22 called us on 9/15/22 to report had started on 9/13 with rash on arm and upper body leading to tongue, went to allergist on 9/13 received epipen, went to er on 9/14 received another epipen and steroids.  Spoked to pt on 9/18 and says doing fine.
Reaction to A-Fib medications Metoprolol and flecainide. Rapid heart rate, high blood pressure, body shaking, loss of apatite. extreme exhaustion.
Patient received pediatric dose of Hep B vaccine instead of adult Hep B (This was her 3rd Hep B vaccine of the series).
I passed out immediately; severe sweating immediately; My tongue felt thick for the next 12+ hours; Itching at the site started the next day and lasted for a week.; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0177, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 18May2021 12:30 (at the age of 65-years-old) as dose 1, single for COVID-19 immunisation in hospital. Medical history included Crohn's (in remission), Graves (in remission), Hashimoto's and celiac. perfume sensitivity and COVID-19. Concomitant medications included liothyronine sodium (CYTOMEL) taken for an unspecified indication, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sulfa g and experienced drug hypersensitivity, antibiotics and experienced drug hypersensitivity, peppermint bell and experienced drug hypersensitivity, nickel and experienced allergy to metals. On 18May2021 at 12:30, she passed out immediately, severe sweating immediately, her tongue felt thick for the next 12+ hours and itching at the site started the next day and lasted for a week. Since the vaccination, the patient has not been tested for COVID-19. The patient did not received treatment for the events. The clinical outcome of the events was resolved on an unspecified date of May2021.  Information on Lot/Batch number was available. Additional information has been requested
Right arm swollen and red starting 24 hours later with redness in upper arm radiated to lower forearm with increased swelling during the day; low grade temperature. Mom called doctor; instructed to give Benadryl and Motrin.
Received both the influenza vaccine and the new pertussis/diphtheria/tetanus in my right deltoid.  My arm swelled up the next day and developed a mild cellulitis.
pt recv vax;found to be pregnant;exp extreme n & v & devel thrombosis hemorrhoids;at 40 wk pt delivered nl baby;
PATIENT CAME TO PICK UP ANOTHER PRESCRIPTION ON 7/14/18 AND MENTIONED SHE RECEIVED A VACCINE ABOUT 10 DAYS AGO. SHE STATED HER ARM IS STILL SORE AND AT ONE POINT RADIATED DOWN HER ARM. RPH SAID THAT A SORENESS IS THE NUMBER ONE REPORTED EFFECT FROM THIS VACCINE, BUT THE SORENESS SHOULD HAVE SUBSIDED BY NOW. RPH ALSO SAID THAT SINCE THE SHOT WAS IN THE MUSCLE, THIS MAY BE WHY STILL SORE. PT ADVISED TO MONITOR AND IF CONDITION GETS WORSE OR DOESN'T IMPROVE TO CONTACT DR.
Headache, Myalgia, NauseaVomiting, increased BP, chills, hot flashes, light headedness Narrative:
painful bumps on the right side, under my neck. They looked like painful zits. Went to the dermatologist and was diagnosed with shingles. It has since cleared up
received an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 55-year-old male patient who received HAB (Twinrix) (batch number 4F3YY, expiry date 1st January 2023) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st March 2023, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 1st March 2023, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 01-MAR-2023 Reporter's Comment: The health care professional reported that the patient received a dose of Twinrix, which was already expired. The reporter consented to follow up. Additional Supportive Information: The use of Twinrix, which was already expired on 1st January 2023, which led to expired vaccine used.
Massive headaches; very bad arm pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the arm right on 22Mar2021 at 13:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer and diagnosed COVID-19. The patient had no allergies to medications, food, or other products. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) and venlafaxine (MANUFACTURER UNKNOWN) taken for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021 the patient experienced massive headaches and very bad arm pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of events massive headaches and very bad arm pain were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient complains of pain in arm that has limited his ability to raise his arm above his head.  As this has been a month since injection it is concerning and patient is going to go see primary care doctor when they are available.  COVID-19 and the restrictions around seeing primary care doctor has delayed his ability to seek medical attention.
Pt states significant arm swelling, arm was hard to the touch, red and painful. Pt also had body aches, fatigue and fever for 3+days that required the patient to be out of work for 2 days.
Vaccine administered after after 4 temperature excursions; Vaccine administered after after 4 temperature excursions; No aderse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No aderse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions).    No relevant concomitant medications were reported. Vaccine was moved from freezer to refrigerator on 12/02/22. Of the ten vials in question 43 injections were given and 7 doses were wasted. No treatment medication reported.  This case contains information for the 5th of 43 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-689222 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-689222:
Moderna Dose 1 3/24/21 (016B21A) Moderna Dose 2 4/21/21 (048B21A) Moderna Dose 3 1/7/22 (lot NA) COVID Positive 2/25/22  2/25/22: A 59-year-old gentleman presented to Hospital as a transfer from ED with a history of persistent cough and shortness of breath for a week.  The patient reports increasing shortness of breath with activities.  He has completed a course of Z-Pak and steroid. However, the symptoms have not improved.  He denies fever. He denies chest pain, though he has pain on the rib related to cough.  The patient reports that he was vaccinated x2 with Moderna and has received his boost for COVID.  3/2/22: P.o. Levaquin course for 10 days per ID  Nebulizer treatments  P.o. prednisone course  P.o. Eliquis  P.o. amiodarone  Breo Ellipta  Metoprolol tartrate 50 mg b.i.d.  Follow-up with ID in 4 weeks  Follow-up with EP Cardiology as outpatient in 1-2 weeks  Follow-up with PCP in 3-5 days  Hemodynamically stable for discharge  Will discharge home  Patient agrees with plan of care
Patient had several episodes of limpness 15-18 hours after receiving a DTaP in the physician's office.  04/23/2008 MR received for DOS 1/31-2/1/2008 with D/C DX: Hypotonic-hyporesponsive episode of unknown etiology.  Pt presented to local ER with episode of limpness with unresponsiveness lasting about 1 min one day s/p vax.  Pt had another episode in ER lasting ~30 sec. Neuro consult with normal exam.  No further episodes.
Vomited x 2 since midnight. Fever to 102.2 with blurred vision short term. Headache. SOB from a few hours after shot until midnight. (L) arm soreness. Feels weak.
Patient reported one week after the vaccine breaking out in hives on her hands, arms and legs as well as arm numbness that lasted for one week.
Initial report received from a healthcare professional on 05 June 2012. A 43-year-old female patient, whose medical history and concomitant medications were not reported, received a intramuscular dose of ADACEL (lot number - U4046AA and site of administration right deltoid). It was reported that the patient had injection site pain. The patient was given corrective treatment of MOTRIN in 13 April 2012. On 21 May 2012, the patient called and reported that she had complaint of difficulty moving right arm with pain radiating to right neck, back and shoulder area and also had headache. The patient was seen by physician and prescribed NAPROSYN and advised physical therapy. The reporter stated that patient had refused the treatment. The outcome of events were reported as unknown. Documents held by sender: none. Follow up information was received on 10 August 2012. The patients illness at the time of vaccination were not known.
I had a positive PCR test; I had a positive PCR test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 05Apr2021 at 12:00 as dose 1, single (Lot number: Er8737), on 26Apr2021 at 12:00 as dose 2, single (Lot number: Er970) and on 15Apr2022 at 19:00 as dose 4 (booster), single (Lot number: Fk9893) at the age of 65 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 27Oct2021 at 14:00 as dose 3 (booster), single (Lot number: 017f21a) for covid-19 immunisation. The patient had no relevant medical history. Patient did not receive other medication in 2 weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 22May2022, outcome "recovered" (2022) and all described as "I had a positive PCR test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22May2022) Positive, notes: I had a positive PCR test and was prescribed Paxlovid; (2022) positive, notes: After starting Paxlovid my symptoms went away. However, I continued to test positive throughout the treatment and have continued to test positive now for 8 more days so far. I never tested negative during or after the treatment; (2022) positive, notes: I tested at day 3 of treatment (positive) and everyday since completing the pills. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient started Paxlovid on 26May2022 and stopped on 30May2022 for the treatment of COVID-19.
fever 102; chills; vomiting; diarrhea; abdominal pain; fatigue; nausea; This is a spontaneous report received from a contactable other hcp. A 62-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EI9265) via an intramuscular route of administration in Arm Left on 23Feb2021 08:30 (age at vaccination 62years old) as single dose for covid-19 immunisation. the patient has not received any other vaccines around the time of Pfizer-BioNTech COVID-19 Vaccine. Medical history included hypersensitivity from an unknown date and unknown if ongoing Medication: Sulpha, allergy to arthropod bite from an unknown date and unknown if ongoing, thrombocytopenia from an unknown date and unknown if ongoing. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9261) via an intramuscular route of administration in Arm right on 05Feb2021 15.30 PM (age at vaccination 62years old) as single dose for covid-19 immunisation. The patient's concomitant medications were not reported. The patient experienced fever 102, chills, vomiting, diarrhoea, abdominal pain, nausea on 24Feb2021, and fatigue on 25Feb2021. The patient underwent lab tests and procedures which included body temperature increased: 102 on unspecified date. The patient did not receive any treatment for the adverse events. The clinical outcome of the events was recovered.  No follow-up attempts are needed. No further information is expected.
sores in mouth on gums, roof, cheeks. dry lump in throat that ached and water wouldn't quench it.
nausea. vomiting. stomach pain.  existing acid reflux is much worse.  lack of appetite.  this is over about 36 hour period.  sleep disruption due to stomach pain and acid in throat.  drinking both decaf black tea and regular green tea with honey, milk.  occassional calcium carbonate chew.  also some swelling and tightness in ankles, feet, and shins. massages to these areas.  digestive disruptions are the most painful and disruptive.
rash; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable consumer (patient) reported that a 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685) , via an unspecified route of administration on 20Dec2020 at single dose for covid-19 immunisation .  Medical history reported as none.  There were no concomitant medications.  The patient experienced rash on 20Dec2020 about an hour after receiving the vaccine. The patient did put some lotion on rash. The outcome of event was not recovered.
Awoke early to a pain in my leg. It was 36 hours after my vaccine.  There was a large blister with a red ring around it that eventually burst about 12 hours later. Now it is an exposed wound with a red ring around it that is slowly healing.